This pipeline maps genes, with mutation or copy number alteration AND this alteration is highly correlated with mRNA expression, to pathways curated in the KEGG and BIOCARTA databases. It identifies pathways significantly enriched with these genes. The pipeline also identifies pathways significantly enriched with marker genes of each expression subtype of cancer.
genes with mutation: identified by the Mutation_Significance pipeline
genes with copy number alteration: identified by the CopyNumber_Gistic2 pipeline
correlation between copy number and mRNA expression: identified by the Correlate_CopyNumber_vs_mRNA pipeline
marker genes and expression subtypes: identified by the mRNAConsensusClustering pipeline
There are 61 genes with significant mutation (Q value <= 0.1) and 368 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 2000 for subtype 1, 2000 for subtype 2, 2000 for subtype 3, 2000 for subtype 4. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :
3 pathways significantly enriched with genes with copy number alteration or mutation.
2 pathways significantly enriched with marker genes of gene expression subtype 1
0 pathways significantly enriched with marker genes of gene expression subtype 2
1 pathways significantly enriched with marker genes of gene expression subtype 3
1 pathways significantly enriched with marker genes of gene expression subtype 4
Pathway | Nof Genes | Nof CNV_Mut | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_PANCREATIC_CANCER | 70 | 9 | 2.6 | 0 | 0.0022 |
KEGG_PROSTATE_CANCER | 89 | 10 | 2.5 | 0 | 0.0022 |
BIOCARTA_TNFR1_PATHWAY | 29 | 6 | 3.3 | 0 | 0.0024 |
BIOCARTA_HIVNEF_PATHWAY | 56 | 7 | 2.6 | 0.0001 | 0.011 |
BIOCARTA_FAS_PATHWAY | 30 | 5 | 3 | 0.0003 | 0.021 |
CHUK,RB1,ERBB2,BCL2L1,TGFBR2,SMAD4,RAF1,SMAD2,IKBKB
HSP90AB1,PTEN,CHUK,HSP90AA1,RB1,FGFR1,ERBB2,TCF7L2,RAF1,IKBKB
PRKDC,BAG4,CASP3,CASP8,MAP2K4,RB1
BAG4,CASP3,CASP8,CHUK,RB1,PSEN1,PRKDC
PRKDC,CASP3,CASP8,MAP2K4,RB1
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 118 | 25 | 1.3 | 0 | 0.0038 |
KEGG_LYSOSOME | 121 | 24 | 1.2 | 0.0001 | 0.0097 |
KEGG_GAP_JUNCTION | 90 | 17 | 1.1 | 0.0014 | 0.097 |
KEGG_NOTCH_SIGNALING_PATHWAY | 47 | 11 | 1.4 | 0.002 | 0.1 |
KEGG_MISMATCH_REPAIR | 23 | 7 | 1.8 | 0.0027 | 0.11 |
MMP9,VCL,RAPGEF4,PIK3CG,PIK3CD,ACTN1,CTNNA2,ITGAL,GNAI3,RAC2,VAV2,PLCG2,RAP1B,CLDN8,PRKCG,TXK,CLDN18,CLDN10,CDH5,VCAM1,EZR,MLLT4,CLDN23,MAPK13,MAPK14
AP4M1,ACP5,PPT2,PPT1,SLC11A2,SCARB2,ENTPD4,LAPTM4B,LAMP2,ASAH1,GLB1,CLN3,ATP6V1H,SORT1,CTSC,CTSH,CLN5,TCIRG1,PSAP,AP4S1,MANBA,ARSA,CTNS,GGA3
ADCY3,TUBB2A,GUCY1A3,PRKACB,RP11-631M21.2,TUBB1,PLCB1,TUBA1A,PLCB2,TUBA1C,PRKCG,ADRB1,GUCY1B3,GNAI3,MAP3K2,MAP2K1,HTR2B
LFNG,PTCRA,KAT2A,KAT2B,DTX3L,DTX2,DLL3,NOTCH1,EP300,PSEN1,RBPJ
EXO1,SSBP1,MLH3,POLD3,RPA1,RFC5,RPA2
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 26 | 8 | 1.8 | 0.0012 | 0.095 |
KEGG_ENDOCYTOSIS | 183 | 29 | 0.88 | 0.0007 | 0.095 |
KEGG_HEMATOPOIETIC_CELL_LINEAGE | 88 | 17 | 1.2 | 0.0008 | 0.095 |
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 118 | 21 | 1 | 0.0009 | 0.095 |
BIOCARTA_LAIR_PATHWAY | 17 | 6 | 2 | 0.0022 | 0.14 |
NDST3,HS3ST6,NDST4,NDST2,HS3ST2,HS6ST3,GLCE,HS3ST3B1
CHMP5,CHMP4A,VPS4B,DNAJC6,ITCH,PLD1,HLA-A,HLA-E,HLA-G,HLA-F,ACAP1,ARFGAP3,FGFR4,ADRBK1,ARF6,AP2M1,CSF1R,NEDD4,CLTA,ZFYVE20,CXCR4,RAB11FIP4,RAB11FIP2,ADRB2,CHMP1B,HSPA2,EHD1,CBL,RAB31
CD8A,GYPA,GP5,CD44,MS4A1,THPO,CD3G,CD3D,CD7,CSF1R,IL7,CD1C,CD1B,ITGA2,CD55,CD19,IL5RA
MMP9,RAPGEF4,PIK3CG,ROCK2,NCF4,MYL7,GNAI2,RAC2,VAV3,VAV2,VAV1,PLCG2,CLDN8,CLDN5,CXCR4,ICAM1,CLDN17,CLDN10,CDH5,VCAM1,RASSF5
KNG1,C7,ICAM1,IL8,VCAM1,SELPLG
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 72 | 7 | 3.2 | 0 | 0.0027 |
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 70 | 6 | 3.1 | 0.0001 | 0.012 |
KEGG_GLUTATHIONE_METABOLISM | 50 | 4 | 3 | 0.0016 | 0.17 |
KEGG_O_GLYCAN_BIOSYNTHESIS | 30 | 3 | 3.3 | 0.0035 | 0.29 |
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 118 | 5 | 2 | 0.0068 | 0.45 |
ADH1C,ADH1A,CYP2A6,GSTA2,GSTA3,GSTA5,MGST1
ADH1C,ADH1A,GSTA2,GSTA3,GSTA5,MGST1
GSTA2,GSTA3,GSTA5,MGST1
GALNT4,GALNTL2,ST6GALNAC1
CLDN2,CLDN15,NOX1,MAPK12,MAPK14
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_AXON_GUIDANCE | 129 | 25 | 1.5 | 0 | 0.0006 |
KEGG_TGF_BETA_SIGNALING_PATHWAY | 86 | 14 | 1.2 | 0.002 | 0.34 |
BIOCARTA_TEL_PATHWAY | 18 | 5 | 2 | 0.0064 | 0.36 |
KEGG_PHENYLALANINE_METABOLISM | 18 | 5 | 2 | 0.0064 | 0.36 |
KEGG_LYSOSOME | 121 | 16 | 0.91 | 0.0087 | 0.36 |
EFNA1,EFNA2,EFNA3,UNC5C,ROCK2,RND1,EFNA5,EPHB2,KRAS,EPHA5,EPHA4,SEMA6B,SEMA6D,NELL1,SEMA3E,SEMA3C,ABLIM1,ABLIM2,ABLIM3,CHP,PPP3CA,NFATC1,DPYSL2,NRAS,FYN
E2F4,E2F5,ZFYVE9,RBL2,ROCK2,RBL1,LEFTY1,INHBB,AMH,TFDP1,SMAD7,SMAD5,ID3,BMP5
XRCC5,HSP90AA1,POLR2A,KRAS,TNKS
DDC,PAH,AMH,PRDX6,HPD
GNPTG,GNS,CTSL2,NAGLU,ENTPD4,LAPTM4B,AP3S1,AP1S3,ATP6V0D1,CLN3,CLN5,CTSF,NAGPA,GNPTAB,CEL,MANBA
Let genes with copy number alteration or mutation be query genes. Let marker genes of specific identified subtypes be query genes. The Enrichment is calculated as:
-
Enrichment = log2 (# of query genes in the pathway/# No of query genes) - log2 (# of genes in the pathway/# of human genes)
The statistical signficance of the pathways that are enriched with genes with copy number alteration or mutation, and the pathways that are enriched with markers genes of specific identified subtypes is measured by P value.
-
P value = Fisher exact P value
The Q value is for adjusting P value for multiple testing. A public available R package is used to calculate the Q value.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.